© 1998 Oxford University Press
other |
A prospective study of dementia with Lewy bodies
MRC Neurochemical Pathology Unit, Newcastle General Hospital Westgate Road, Newcastle upon Tyne NE4 6BE, UK
1Brighton Clinic, Elderly Annexe, Newcastle General Hospital Westgate Road, Newcastle upon Tyne
2Institute for the Health of the Elderly, Elderly Annexe, Newcastle General Hospital Westgate Road, Newcastle upon Tyne
3Bensham Hospital Gateshead, Tyne and Wear, UK
4Department of Neuropathology, University of Newcastle upon Tyne
Correspondence Address correspondence to: C. Ballard. Fax: (+44) 191 272 5291
Background: little is known about the longitudinal course of dementia with Lewy bodies (DLB) and how this differs from Alzheimer's disease (AD).
Method: standardized baseline and annual assessments of cognitive and non-cognitive symptoms are reported in a cohort of 72 patients with DLB or AD. AD was diagnosed using the NINCDS ADRDA criteria and DLB was diagnosed with the criteria of McKeith et al. Cognitive assessment was undertaken using the MMSE schedule and operationalized definitions were used to diagnose non-cognitive symptoms.
Results: 42 patients with DLB and 30 patients with AD were assessed. Of the 19 on whom post mortem examinations have been performed, 18 (95%) have had the clinical diagnosis confirmed. DLB patients were significantly more likely to experience visual hallucinations, disturbances of consciousness and parkinsonism at both baseline and at annual assessments. Of DLB patients exposed to neuroleptics, 33% developed sensitivity reactions. The magnitude and pattern of cognitive decline was similar in both groups.
Conclusion: the importance of the core features highlighted in the newly proposed consensus DLB criteria is supported. These features appear to be stable over time.
Keywords: Alzheimer's disease, dementia with Lewy bodies, prospective study
Received July 5, 1997; accepted in revised form October 31, 1997.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
K. Stavitsky, A. M. Brickman, N. Scarmeas, R. L. Torgan, M.-X. Tang, M. Albert, J. Brandt, D. Blacker, and Y. Stern The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease. Arch Neurol, October 1, 2006; 63(10): 1450 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Bradshaw, M Saling, M Hopwood, V Anderson, and A Brodtmann Fluctuating cognition in dementia with Lewy bodies and Alzheimer's disease is qualitatively distinct J. Neurol. Neurosurg. Psychiatry, March 1, 2004; 75(3): 382 - 387. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Piggott, E. F. Marshall, N. Thomas, S. Lloyd, J. A. Court, E. Jaros, D. Burn, M. Johnson, R. H. Perry, I. G. McKeith, et al. Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution Brain, August 1, 1999; 122(8): 1449 - 1468. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ballard, C. Holmes, I. McKeith, D. Neill, J. O'Brien, N. Cairns, P. Lantos, E. Perry, P. Ince, and R. Perry Psychiatric Morbidity in Dementia With Lewy Bodies: A Prospective Clinical and Neuropathological Comparative Study With Alzheimer's Disease Am J Psychiatry, July 1, 1999; 156(7): 1039 - 1045. [Abstract] [Full Text] |
||||



